Image to Impact
Inotek Pharmaceuticals is a biotechnology company based in Lexington, MA, focused on developing innovative drugs for serious eye diseases, including glaucoma and retinal disorders. Their lead program, trabodenoson (INO-8875), is a novel adenosine mimetic designed to lower intraocular pressure associated with open-angle glaucoma and ocular hypertension, having shown promising results in clinical trials.
The company boasts an experienced management team with a history of successful new drug applications and a robust pipeline targeting inflammation and oxidative stress in eye health. Inotek is dedicated to advancing their clinical programs to provide effective treatments for patients suffering from ocular diseases.
Generated from the website
Also at this address
You might also like
Partial Data by Foursquare.